MedDataX Logo

Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus

NCT ID: NCT04924777

Last Updated: 2021-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-01

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study design is to determine the effectiveness of moderate physical activity on g;lycemic control in type 2 diabetes mellitus.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To the best of authors knowledge so far the studies have been conducted on different modes of moderate physical activity on glycemic control in type 2 diabetes, current study goal is to evaluate which mode of moderate physical activity has more significant result on glycemic control in type 2 diabetes and is sustainable in Pakistani society according to the socioeconomic status and cost effectiveness of the modes of moderate physical activity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brisk walk

Group Type EXPERIMENTAL

Brisk Walk

Intervention Type OTHER

1-Brisk walk for 30 minutes 2-5 days a week 3-3months

Strength training

Intervention Type OTHER

1-Strength Training Exercises for 30 minutes. 2-5 days a week 3-3 months

Aerobic Exercises

Intervention Type OTHER

1-Aerobic exercises for 30 minutes 2-5 Days a week 3-3months

Aerobic Training

Group Type EXPERIMENTAL

Brisk Walk

Intervention Type OTHER

1-Brisk walk for 30 minutes 2-5 days a week 3-3months

Strength training

Intervention Type OTHER

1-Strength Training Exercises for 30 minutes. 2-5 days a week 3-3 months

Aerobic Exercises

Intervention Type OTHER

1-Aerobic exercises for 30 minutes 2-5 Days a week 3-3months

Strength Training

Group Type EXPERIMENTAL

Brisk Walk

Intervention Type OTHER

1-Brisk walk for 30 minutes 2-5 days a week 3-3months

Strength training

Intervention Type OTHER

1-Strength Training Exercises for 30 minutes. 2-5 days a week 3-3 months

Aerobic Exercises

Intervention Type OTHER

1-Aerobic exercises for 30 minutes 2-5 Days a week 3-3months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brisk Walk

1-Brisk walk for 30 minutes 2-5 days a week 3-3months

Intervention Type OTHER

Strength training

1-Strength Training Exercises for 30 minutes. 2-5 days a week 3-3 months

Intervention Type OTHER

Aerobic Exercises

1-Aerobic exercises for 30 minutes 2-5 Days a week 3-3months

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants falling in this category would be recruited into the study.
* Male/female
* Diabetic type 2 patients
* Age: 30-70 years
* BMI \>25
* Overweight
* Fat % in male\> 25
* Fat % in female \>35
* HbA1c level more than 48mmol/mol or \>6.5%
* Fasting Plasma Glucose level \>126 mg/dl (7.0 mmol/l)
* Random Plasma glucose level \>200 mg/dl (11.1 mmol/l)
* Physically active ( have no mobility problems)

Exclusion Criteria

* Participant failing to fall in this category would be excluded of the study.
* Type 1 diabetes
* Insulin dependant type 2 diabetes
* Gestational Diabetes
* Hypertension
* Cigarette smoking
* Cardiovascular Disease
* Cerebrovascular disease
* Cardiopulmonary Disorders
* Cognition Problems
* Peripheral Artery Disease
* Dyslipidemia
* Proliferative or preproliferative retinopathy
* Nephropathy
* Neuropathy
Minimum Eligible Age

30 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Waqar Ahmad Awan

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Riphah Rehabilitation Center

Islamabad, , Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/0929 Zainab Qadri

Identifier Type: -

Identifier Source: org_study_id